The Relationship Between Serum C-Reactive Protein and Daily Physical Activity in Japanese Hypertensive Patients

REFERENCES

• Kubo M, Hata J, Doi Y, Tanizaki Y, Iida M, Kiyohara Y. Secular trends in the incidence of and risk factors for ischemic stroke and subtypes in Japanese population. Circulation 2008;118:2672–2678.
   PubMed Web of Science ®Google Scholar
• Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, Levy D. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001;345:1291–1297.
   PubMed Web of Science ®Google Scholar
• Chobaian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Classification of Blood Pressure. Hypertension 2003;42:1206–1252.
   PubMed Web of Science ®Google Scholar
• Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135–1143.
   PubMed Web of Science ®Google Scholar
• Pfutzner A, Forst T. High-sensitive C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. Diabetes Technol Ther 2006;8:28–36.
   PubMed Web of Science ®Google Scholar
• Bautista LE, Lopez-Jaramillo P, Vera LM, Casas JP, Otero AP, Guaracao AI. Is C-reactive protein an independent risk factor for essential hypertension?? J Hypertens 2001;19:857–861.
   PubMed Web of Science ®Google Scholar
• Choi H, Cho DH, Shin HH, Park JB. Association of high sensitivity C-reactive protein with coronary heart disease prediction, but not with carotid atherosclerosis, in patients with hypertension. Circ J 2004;68:297–303.
   PubMed Web of Science ®Google Scholar
• Dickey RA, Janick JJ. Lifestyle modifications in the prevention and treatment of hypertension. Endocr Pract 2001;7:392–399.
   PubMedGoogle Scholar
• Appel LJ. Nonpharmacologic therapies that reduce blood pressure: a fresh perspective. Clin Cardiol 1999;22:III1–5.
   PubMed Web of Science ®Google Scholar
• Pinto A, Di Raimondo D, Tuttolomondo A, Fernandez P, Arnao V, Licata G. Twenty-four hour ambulatory blood pressure monitoring to evaluate effect on blood pressure of physical activity in hypertensive patients. Clin J Sport Med 2006;16:238–248.
   PubMed Web of Science ®Google Scholar
• Xu T, JU Z, Tong W, Hu W, Liu Y, Zhao L, Zhang Y. Relationship of C-reactive protein with hypertension and interactions between increased C-reactive protein and other risk factors on hypertension in Mongolian people, China. Circ J 2008;72:1324–1328.
   PubMed Web of Science ®Google Scholar
• Niskanen L, Laaksonen DE, Nyyssonen K, Punnonen K, Valkonen V, Fuentes R, Tuomainen T, Salonen R, Salonen JT. Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension 2004;44:859–865.
   PubMed Web of Science ®Google Scholar
• Imhof A, Froehlich M, Brenner H, Boeing H, Pepys MB, Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet 2001;357:763–767.
   PubMed Web of Science ®Google Scholar
• Onat A, Hergenc G, Dursunoglu D, Ordu S, Can G, Bulur S, Yuksel H. Associations of alcohol consumption with blood pressure, lipoproteins, and subclinical inflammation among Turks. Alcohol 2008;42:593–601.
   PubMed Web of Science ®Google Scholar
• Nakandakare ER, Charf AM, Santos FC, Nunes VS, Ortega K, Lottenberg AM, Mion D JR, Nakano T, Nakajima K, D' Amico EA, Catanozi S, Passarelli M, Quintao EC. Dietary salt restriction increases plasma lipoprotein and inflammatory marker concentration in hypertensive patients. Atherosclerosis 2008;200:410–416.
   PubMed Web of Science ®Google Scholar
• Niu K, Hoawa A, Fujita K, Ohmori K, Okutsu M, Kuriyama S, Tsuji I, Nagatomi R. Influence of leisure-time physical activity on the relationship between C-reactive protein and hypertension in a community-based elderly population of Japan: The Tsurugaya project. Hypertens Res 2005;28:747–754.
   PubMed Web of Science ®Google Scholar
• Matthews KA, Sowers MF, Derby CA, Stein E, McMahill HM, Grawford SL, Pasternak RC. Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women's Health Across the Nation. Am Heart J 2005;149:1066–1073.
   PubMed Web of Science ®Google Scholar
• Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A, Matthews KA, Johnston J, Sowers MR, Sternfeld D, Paternak RC, Chae CU, SWAN Investigators. Ethnic difference in C-reactive protein concentrations. Clin Chem 2008;54:1027–1037.
   PubMed Web of Science ®Google Scholar
• Hsieh SD, Yoshinaga H, Muto T, Sakurai Y. Regular physical activity an coronary risk factors in Japanese men. Circulation 1998;97:661–665.
   PubMed Web of Science ®Google Scholar
• Faul F, Erdfelder E, Lang AG, Buchner A. G**Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39: 175–191.
   PubMed Web of Science ®Google Scholar
• Higashi Y, Yoshizumi M. Exercise and endothelial function: role of endothelium-derived nitric oxide and oxidative stress in healthy subjects and hypertensive patients. Pharmacol Ther 2004;102:87–96.
   PubMed Web of Science ®Google Scholar
• Borodulin K, Laatikainen T, Salomaa V, Jousilahti P. Association of leisure time physical activity, self-rated physical fitness, and estimated aerobic fitness with serum C-reactive protein among 3,803 adults. Atherosclerosis 2006;185:381–387.
   PubMed Web of Science ®Google Scholar
• van Gils CH, Peeters P. H.M, Schoenmakers M. C.J, Nijmeijer RM, Onland-Moret NC, van der Schouw YT, Monninkhof EM. Physical activity and endogenous sex hormone levels in postmenopausal women: cross sectional study in the prospect-EPIC cohort. Cancer Epidemiol Biomarkers Prev 2009;18:377–383.
   PubMed Web of Science ®Google Scholar
• Stork S, Bots ML, Grobee DE, van der Schouw YT. Endogenous sex hormone and C-reactive protein in healthy postmenopausal women. J Intern Med 2008;264:245–253.
   PubMed Web of Science ®Google Scholar
• Muller M, den Tonkelaar I, Thijssen JH, Grobbee DE, van der Schouw YT. Endogenous sex hormone in men aged 40–80 years. Eur J Endocrinol 2003;149:583–589.
   PubMed Web of Science ®Google Scholar
• Van Pottelbergh I, Braeckman L, De Bacquer D, De Backer G, Kaufman JM. Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in middle-aged men. Atherosclerosis 2006;166:95–102.
   Google Scholar
• Maggio M, Basaria S, Ble A, Laurentani F, Bansinelli S, Ceda GP, Valenti G, Ling SM, Ferrucci L. Correlation between testosterone and the inflammatory marker soluble interleukin-5 receptor in older men. J Clin Endocrinol Metab 2006;91:345–347.
   PubMed Web of Science ®Google Scholar
• Hjelstuen A, Anderssen SA, Holme I, Seljeflot I, Klemsdal TO. Marcers of inflammation are related to physical activity and fitness in sedentary men with treated hypertension. Am J Hypertens 2006;19:669–675.
   PubMed Web of Science ®Google Scholar
• Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City diabetes study. Diabetes Care 2002;25:2016–2021.
   PubMed Web of Science ®Google Scholar
• Sesso HD, Burging JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and risk of developing hypertension JAMA 2003; 290:2945–2951.
   PubMed Web of Science ®Google Scholar